Mesoblast | MSB - Sales Revenues

Stock Price
2.23
Daily Change
-0.16 -6.69%
Monthly
-18.32%
Yearly
-28.75%
Q1 Forecast
2.48

Mesoblast reported $13.2M in Sales Revenues for its fiscal semester ending in June of 2025.





Sales Change Date
Avita Medical AUD 18.42M 14K Jun/2025
Clinuvel Pharmaceuticals AUD 55.92M 23.66M Jun/2024
Cochlear AUD 585.65M 586.15M Jun/2025
CSL USD 3.54B 4.68B Jun/2025
Pacific Edge NZD 5.94M 4.95M Dec/2025
Paradigm Biopharmaceuticals AUD -8K 441.66K Jun/2025
PYC Therapeutics AUD 13.48M 786.97K Jun/2025
Ramsay Health Care AUD 9.29B 32.2M Dec/2025
Sonic Healthcare AUD 4.98B 311M Jun/2025
Starpharma Holdings AUD 1.71M 717K Jun/2025
Telix Pharmaceuticals AUD 309.72M 109.32M Jun/2025